CLINICAL TRIAL PATIENT TECHNOLOGY INSIGHTS
-
eClinical Solutions Market To Double In 5 Years, As Sponsors Prioritize Efficiency
The global eClinical solutions market is projected to reach $22.1 million in 2029, double its presence in 2024. Experts discuss the specific solutions driving market growth and share how they impact clinical operations.
-
Is Double Programming Really Required For Validation?
Double programming has been the gold standard for validation, but technological advancements and improved sponsor oversight of CRO deliverables have introduced more efficient and reliable alternatives.
ECOA RESOURCES
-
Discover new possibilities where patients can complete several of their clinical study procedures remotely, making their participation in clinical trials easier and less cumbersome than site-based trials.
-
Greta van Schoor attended the 31st Annual ISOQOL Conference, where HRQOL leaders shared insights on optimizing eCOA collection, integrating PROs, and digital health in clinical research.
-
Consider this expedited review approach to facilitate the efficient evaluation of COAs and eCOAs, streamlining the pathway for successful trial execution.
ECONSENT RESOURCES
-
The right technology and community partnerships can help sponsors meet FDA diversity requirements without additional expenditures, build relationships with minorities, and prepare for future trials.
-
Sites juggle dozens of applications, which increases their workload and limits their capacity. Sites need an industry-wide single sign-on experience that brings key systems and applications under one roof.
-
Empower your patients throughout the clinical trial journey and eliminate the barriers and friction that get in their way with YPrime's eConsent platform.
EPRO RESOURCES
-
The right technology and community partnerships can help sponsors meet FDA diversity requirements without additional expenditures, build relationships with minorities, and prepare for future trials.
-
Greta van Schoor attended the 31st Annual ISOQOL Conference, where HRQOL leaders shared insights on optimizing eCOA collection, integrating PROs, and digital health in clinical research.
-
In oncology trials, safety and tolerability are a core focus. From centralized ECGs to patient-reported outcomes, utilize this guide for optimizing assessments of drug safety and quality of life.